跳至主要内容
临床试验/NCT06287606
NCT06287606已完成3 期

A Prospective, Randomized, Investigator-blinded, Parallel, Multi-center, Phase 3 Trial in Bowel Preparation for Colonoscopy

Taejoon Pharmaceutical Co., Ltd.1 个研究点 分布在 1 个国家目标入组 161 人开始时间: 2023年8月29日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
161
试验地点
1
主要终点
Ratio of subjects With successful Bowel Cleansing

研究概览

简要总结

A prospective randomized study compared to the active control. Researchers compare colon cleansing in patients undergoing colonoscopy

详细描述

This is a prospective randomized study compared with active control arm. The investigators compare the colon cleansing in patients undergoing colonoscopy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients must provide written informed consent.
  • Male and female outpatients and inpatients aged: ≥19
  • Patients BMI shoule be ≤ 30

排除标准

  • Patients with past history of severe constipation (requiring repeated use of laxatives/enema or physical intervention before resolution), known or suspected ileus, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis or megacolon.
  • Patients with ongoing severe acute Inflammatory Bowel Disease.
  • Patients who have had previous significant gastrointestinal surgeries, including colonic resection, subtotal colectomy, abdominoperineal resection, defunctioning colostomy.
  • Pregnant women or pregnant women or pregnant women
  • Severe heart disease (cardiac failure (NYHA class 3 and 4))
  • Acute coronary artery disease within 24 weeks before screening (an unstable angina pectoris, acute myocardial infarction), clinically significant arrhythmia, hypertrophic obstruction Cardiomyopathy, valvular disease, aortic and peripheral vascular diseases.
  • People who have hypersensitivity or allergies to clinical trial drug components.

研究组 & 干预措施

CTP0302-A

Experimental

2 days split-dose

干预措施: CTP0302-A (Drug)

CTP0302-B

Experimental

One day dose

干预措施: CTP0302-B (Drug)

Conventional OST

Active Comparator

2 days split-dose

干预措施: Conventional OST (Drug)

结局指标

主要结局

Ratio of subjects With successful Bowel Cleansing

时间窗: 1 day of scheduled colonoscopy

The overall quality of bowel cleansing was assessed by a blinded central reader (an experienced and trained colonoscopist) using the segmental scores of the Harefield Cleansing Scale (HCS). A final HCS grading of A, B, C or D was derived. Grades A and B are classified as successful (i.e. all mucosa could be visualized) and C and D are classified as unsuccessful.

次要结局

  • Each segments ratio of subject with successful Bowel Cleansing(1 day of scheduled colonoscopy)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验